Code | 9721B | ||||||||||
MA number | 29/0299/16-S | ||||||||||
Product Form: | tbl 20x100 mg (blis.PVC/Al) | ||||||||||
MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
Type of procedure: | Decentralised | ||||||||||
MAH, country: | Sandoz Pharmaceuticals d.d., Slovenia | ||||||||||
Therapeutic Class: | 29 - ANTIRHEUMATICA, ANTIPHLOGISTICA, ANTIURATICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 13.06.2016 |
Pediatric indication: | Yes |
Pediatric posology: | Yes |
SPC: | SPC_Alopurinol_Sandoz_02.2022.pdf |
PIL: | PIL_Alopurinol Sandoz_02.2022.pdf |
Safety feature | Yes |
Data update: | 16.08.2021 |